Aardvark Therapeutics Inc Sustainability Reports
Aardvark Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases and hunger-related disorders.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG01223DLC1
No reports are currently available in our catalogue.